Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Apr 27, 2022; 14(4): 304-314
Published online Apr 27, 2022. doi: 10.4240/wjgs.v14.i4.304
Table 3 Patterns of recurrence

LTG, n = 382
OTG, n = 196
P value
Recurrence, n (%)
No333 (87.2)175 (89.3)0.547
Yes49 (12.8)21 (10.7)
Liver metastasis, n (%)
No372 (97.4)193 (98.5)0.590
Yes10 (2.6)3 (1.5)
Lung metastasis, n (%)
No376 (98.4)192 (98.0)0.941
Yes6 (1.6)4 (2.0)
Bone metastasis, n (%)
No377 (98.7)193 (98.5)1.000
Yes5 (1.3)3 (1.5)
Brain metastasis, n (%)
No380 (99.5)193 (98.5)0.445
Yes2 (0.5)3 (1.5)
Pancreas metastasis, n (%)
No381 (99.7)194 (99.0)0.555
Yes1 (0.3)2 (1.0)
Anastomotic recurrence, n (%)
No369 (96.6)189 (96.4)1.000
Yes13 (3.4)7 (3.6)
Peritoneal dissemination, n (%)
No377 (98.7)196 (100.0)0.257
Yes5 (1.3)0 (0.0)
Lymph node metastasis, n (%)
No377 (98.7)196 (100.0)0.257
Yes5 (1.3)0 (0.0)
Others, n (%)
No378 (99.0)196 (100.0)0.364
Yes4 (1.0)0 (0.0)